Literature DB >> 36242600

Current approaches to the management of pneumatosis intestinalis: an American Pediatric Surgical Association membership survey.

Shannon N Acker1, Sarah Ogle2, Emily Cooper3, Maxene Meier3, Pamela N Peterson4,5, Ann M Kulungowski2.   

Abstract

PURPOSE: Pneumatosis intestinalis (PI) remains difficult to treat as it can lead to a broad range of clinical sequalae and there are little published data available to guide management. Our aim was to evaluate how pediatric surgeons currently manage children with PI, how treatment varies based on etiology, and to identify opportunities to optimize current PI management strategies.
METHODS: We administered a web-based survey of practicing pediatric surgeons in the United States and Canada. The survey was distributed to all members of the American Pediatric Surgical Association.
RESULTS: Of 1508 distributed surveys, 333 responses were received (22% response rate); 174 were complete and included in analysis (12% analyzed). For all scenarios, respondents recommended treatment for PI include a median 7 days of bowel rest and 7 days antibiotics. Only 41% reported their approach to PI management was optimal. Ways to optimize care include treatment based on etiology (83%), decreased number of repeat images (64%), shorter NPO course (49%), and shorter antibiotic course (47%).
CONCLUSION: Pediatric surgeons manage PI similarly regardless of etiology but most report this is suboptimal. Future work is needed to prospectively evaluate management protocols that consider etiology.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  APSA survey; Neutropenic enterocolitis; Pneumatosis intestinalis

Year:  2022        PMID: 36242600     DOI: 10.1007/s00383-022-05249-1

Source DB:  PubMed          Journal:  Pediatr Surg Int        ISSN: 0179-0358            Impact factor:   2.003


  14 in total

1.  Pneumatosis intestinalis after hematopoietic stem cell transplantation: When not doing anything is good enough.

Authors:  Gregory Wallace; Nelson Rosen; Alexander J Towbin; Sonata Jodele; Kasiani C Myers; Stella M Davies; Amanda Flannery; Juan P Gurria
Journal:  J Pediatr Surg       Date:  2021-01-06       Impact factor: 2.545

2.  Pneumatosis intestinalis in a preterm infant: should we treat all intestinal pneumatosis as necrotising enterocolitis?

Authors:  Siu Jun Chew; Rajadurai Samuel Victor; Krishna Revanna Gopagondanahalli; Suresh Chandran
Journal:  BMJ Case Rep       Date:  2018-03-28

3.  Management of neutropenic enterocolitis in children with cancer.

Authors:  Nicklas Sundell; Håkan Boström; Mats Edenholm; Jonas Abrahamsson
Journal:  Acta Paediatr       Date:  2011-10-14       Impact factor: 2.299

Review 4.  Pneumatosis intestinalis in the pediatric oncology population: An 11-year retrospective review at Memorial Sloan Kettering Cancer Center.

Authors:  Kayleen A Bailey; Hemal Kodikara; Audrey Mauguen; Anita Price; Michael LaQuaglia; Farid Boulad
Journal:  Pediatr Blood Cancer       Date:  2021-12-28       Impact factor: 3.167

5.  Pneumatosis intestinalis in children beyond the neonatal period: is it always benign?

Authors:  Alexey Abramov; Valerie L Luks; Felix De Bie; Rosa Hwang; Myron Allukian; Gary W Nace
Journal:  Pediatr Surg Int       Date:  2021-11-27       Impact factor: 1.827

6.  Neutropenic enterocolitis: spectrum of the disease and comparison of definite and possible cases.

Authors:  L Gomez; R Martino; K V Rolston
Journal:  Clin Infect Dis       Date:  1998-10       Impact factor: 9.079

Review 7.  The spectrum of pneumatosis intestinalis.

Authors:  Shawn D St Peter; Maher A Abbas; Keith A Kelly
Journal:  Arch Surg       Date:  2003-01

8.  Management of pneumatosis intestinalis in children over the age of 6 months: a conservative approach.

Authors:  Leel Nellihela; Mohamed Mutalib; David Thompson; Kammermeier Jochen; Manasvi Upadhyaya
Journal:  Arch Dis Child       Date:  2017-10-07       Impact factor: 3.791

Review 9.  A systematic analysis of pneumatosis cystoids intestinalis.

Authors:  Li-Li Wu; Yun-Sheng Yang; Yan Dou; Qing-Sen Liu
Journal:  World J Gastroenterol       Date:  2013-08-14       Impact factor: 5.742

10.  Neutropenic enterocolitis, a growing concern in the era of widespread use of aggressive chemotherapy.

Authors:  Lior Nesher; Kenneth V I Rolston
Journal:  Clin Infect Dis       Date:  2012-11-29       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.